An open label phase 4 trial to further evaluate the pharmacokinetic profile of intravenous daptomycin, and a comparison of the safety and efficacy of daptomycin versus comparator in the treatment of adult patients with renal impairment and complicated skin and skin structure infections due, at least in part, to Gram-positive bacteria

Trial Profile

An open label phase 4 trial to further evaluate the pharmacokinetic profile of intravenous daptomycin, and a comparison of the safety and efficacy of daptomycin versus comparator in the treatment of adult patients with renal impairment and complicated skin and skin structure infections due, at least in part, to Gram-positive bacteria

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2016

At a glance

  • Drugs Daptomycin (Primary)
  • Indications Bacterial infections; Renal impairment; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors Cubist Pharmaceuticals
  • Most Recent Events

    • 19 Jan 2007 Status changed from recruiting
    • 24 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top